The exact treatment for PE depends on its severity and whether you need critical treatment in an emergency room setting. PE medications are usually considered before medical procedures.

The trial adds much-needed randomized data to an area where it’s been lacking. Questions about methods muddy interpretation.

KKR's acquisition of SunFireMatrix and Consello's purchase of EHE Health are among the deals that exemplify the new trends.

Findings from the first international randomized controlled trial to compare patient outcomes following treatment with ...

A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...

Penumbra (NYSE:PEN) today announced new data demonstrating improved outcomes with its computer-assisted vacuum thrombectomy ...

(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.

Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...

Julie Bulman, MD, presented the results of the pilot ENGULF trial. The two-phase, prospective, single-arm study assessed the ...

Global Dyspnea Treatment MarketThe global dyspnea treatment market, valued at USD 5.90 billion in 2022, is expected to experience robust growth, projected to reach approximately USD 12.3 billion by ...

Mandy Stewart has always been a vital part of Holy Spirit football. Now, as she battles breast cancer, the team is rallying ...